Apixaban (eliquis) for stroke prevention in atrial fibrillation.

@article{Beck2014ApixabanF,
  title={Apixaban (eliquis) for stroke prevention in atrial fibrillation.},
  author={Robert A. Beck and William Michael King},
  journal={American family physician},
  year={2014},
  volume={89 8},
  pages={
          672-5
        }
}
2. Dose of apixaban (Eliquis®) 5mg daily twice daily. Therapy should be continued long term. Some patients require a lower dosage of apixaban (See table 1) NICE TA275 published in March 2013. Apixaban is recommended as an option for the prevention of stroke and systemic embolism within its licensed indication, that is, in people with nonvalvular atrial fibrillation with one or more risk factors such as: